Why is Sai Life Sciences Ltd ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.25 times
2
Healthy long term growth as Operating profit has grown by an annual rate 87.31%
3
With a growth in Net Profit of 42.11%, the company declared Very Positive results in Sep 25
- The company has declared positive results for the last 3 consecutive quarters
- OPERATING CF(Y) Highest at Rs 330.35 Cr
- OPERATING PROFIT TO INTEREST(Q) Highest at 15.60 times
- NET SALES(9M) Higher at Rs 1,613.40 cr
4
With ROE of 7.5, it has a Very Expensive valuation with a 7.9 Price to Book Value
- Over the past year, while the stock has generated a return of 0.00%, its profits have risen by 82%
5
High Institutional Holdings at 52.43%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 16.21% over the previous quarter.
How much should you hold?
- Overall Portfolio exposure to Sai Life should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
19.10%
EBIT Growth (5y)
87.31%
EBIT to Interest (avg)
2.36
Debt to EBITDA (avg)
1.56
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
0.68
Tax Ratio
25.14%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
52.43%
ROCE (avg)
11.61%
ROE (avg)
8.71%
Valuation Key Factors 
Factor
Value
P/E Ratio
105
Industry P/E
34
Price to Book Value
7.93
EV to EBIT
69.30
EV to EBITDA
46.93
EV to Capital Employed
7.76
EV to Sales
11.16
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
11.20%
ROE (Latest)
7.53%
Loading Valuation Snapshot...
23What is working for the Company
OPERATING CF(Y)
Highest at Rs 330.35 Cr
OPERATING PROFIT TO INTEREST(Q)
Highest at 15.60 times
NET SALES(9M)
Higher at Rs 1,613.40 cr
PBT LESS OI(Q)
At Rs 96.72 cr has Grown at 34.4% (vs previous 4Q average
PAT(Q)
At Rs 83.84 cr has Grown at 37.4% (vs previous 4Q average
-2What is not working for the Company
DPS(Y)
Lowest at Rs 0.00
DPR(Y)
Lowest at 0.00%
Loading Valuation Snapshot...
Here's what is working for Sai Life
Net Sales - Latest six months
At Rs 1,033.89 cr has Grown at 53.11%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Cash Flow - Annually
Highest at Rs 330.35 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Operating Profit to Interest - Quarterly
Highest at 15.60 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 96.72 cr has Grown at 34.4% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 71.99 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 83.84 cr has Grown at 37.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 61.02 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Sai Life
Dividend per Share (DPS) - Annually
Lowest at Rs 0.00
in the last five yearsMOJO Watch
Company is distributing lower dividend than previous years
DPS (Rs)
Dividend Payout Ratio (DPR) - Annually
Lowest at 0.00%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
Non Operating Income - Quarterly
Highest at Rs 15.33 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income






